MediSafe Expands into Wearables During Google’s I/O Developer Conference; Releases 1st Medication Management App for Android Wear Smartwatches

HAIFA, Israel--At Google’s I/O Developer Conference last month, MediSafe (www.medisafeproject.com) expanded its leading medication management platform to include wearables, becoming the first mobile health app on Google’s just-announced suite of Android Wear smartwatches.

Users wearing either the LG Android Wear, Samsung Gear Live or Moto 360 smartwatches, who also have the MediSafe medication management solution installed on their Android smartphone or tablet, will automatically have a MediSafe “wearable app” loaded on their Android Wear and begin receiving medication reminders on their smartwatch when it’s time to take scheduled doses. They have a choice to record taking doses two different ways:

  • Shake to Take” – Users simply rotate their wrists left-to-right
  • Swipe and Tap – Users swipe-left on their reminder and tap once to confirm

In either scenario, the data is seamlessly transferred to the MediSafe app on their smartphones and tablets via Bluetooth, where it becomes part of their full medication adherence file they can export and email securely to their personal healthcare providers in between office visits.

“Android Wear brings MediSafe one step closer to patients – something central to our mission of connecting patients and healthcare providers for constant, two-way communication around medication management,” said MediSafe CEO Omri ‘Bob’ Shor. “We’re thrilled to be the first wearable medication management solution, and very grateful to Google for the opportunity to expand our platform to Android Wear, allowing us to further improve patients’ health outcomes.”

MediSafe also welcomes partnerships with sensor-based wearables, which would allow it to incorporate vital health statistics, like users’ blood glucose levels, steps taken per day and sleep patterns, with its own data for when users took their medications, plus users’ reported feelings – to give physicians a more complete picture of patients’ lives. With this data all in one place, physicians gain the ability to make more informed decisions about patients.

Today’s Android Wear integration broadens MediSafe’s existing platform, which includes branded versions for hospitals, electronic medical/health records systems (EMR, EHR) and HMOs that send patients medication reminders via the web or SMS – in addition to its flagship mobile app, which was first to sync medication reminders among families’ and caregivers’ mobile devices.

MediSafe’s one-of-a-kind ‘virtual pillbox’ user interface has made it both the top-rated and most-downloaded medication management tool in Google Play and iTunes. Earlier this month, MediSafe won the prestigious Qualcomm Ventures QPrize 2014 over 1,200 international startups, receiving an investment prize of $250,000. By winning the competition, MediSafe joined an investment portfolio that includes other wearable, connected health & fitness leaders.

MediSafe has been downloaded for free in Google Play and the iTunes App Store over 700,000 times, reminded users to take over 35 million doses, and been viewed by users over 60 million times. Its users have an average medication adherence rate of 86%, compared to the 50% average adherence figure for the general population cited by both the World Health Organization (WHO) and the Centers for Disease Control (CDC).

About MediSafe

MediSafe is the leading medication management platform – connecting patients and health providers to improve health outcomes and better understand how people take medication. Inspired by the accidental insulin overdose of its co-founders’ father, MediSafe’s intuitive, singularly designed mobile app – now the most downloaded and highest rated in its category – was first to sync medication reminders between devices of families and caregivers. The MediSafe platform now includes web and SMS sync via branded solutions with pharmaceutical companies, HMOs, pharmacies, electronic medical/health records companies (EMR, EHR) and more. MediSafe also aggregates anonymous patient behavior data for pharmaceutical and healthcare companies, serving as a bridge between patients and health providers, improving health outcomes while benefiting all stakeholders across the healthcare ecosystem. MediSafe’s App can be downloaded from both Google Play and iTunes. For more information, visit www.MediSafeProject.com.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.